Keywords: IS; immunosuppressive; AD; autoimmune disease; HIV; human immunodeficiency virus; PCP; pneumocystis pneumonia; VE; vaccine efficacy; ANCA; antineutrophil cytoplasmatic antibodies; SLE; systemic lupus erythematosus; ASIA; autoimmune inflammatory syndrome i